To test the feasibility of this approach, we first examined expression in extracts from human hepatoma HepG2 cells, a line demonstrating robust SREBP-2 activity, under excess cholesterol and cholesterol depletion. This evidence concerns the gene SREBF2 and hepatocellular carcinoma.